Our finding of a comparable rate of thrombotic events in patients with and without cancer may be significant for assessing the preventive effectiveness of antiplatelet agents for arterial thrombotic events in patients with cancer.
← all excerpts
Incidence of Arterial Thrombotic and Bleeding Events in Patients Who Develop Cancer after ST-elevation Myocardial Infarction.
1
—
—